European Union Approves New Vaccine for Ebola


The European Union approved a new vaccine to prevent Ebola virus disease (Zaire ebolavirus species) in individuals aged 1 year and older.  The vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.

Content Information

Content Author: 
European Union European Medicines Agency

Content Source: 
European Union European Medicines Agency

Content Type: 
News